BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 261 filers reported holding BIONTECH SE in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $224,928 | -0.4% | 2,799 | +14.3% | 0.00% | – |
Q1 2024 | $225,920 | -20.4% | 2,449 | -9.0% | 0.00% | – |
Q4 2023 | $283,903 | -53.2% | 2,690 | -51.8% | 0.00% | -100.0% |
Q3 2023 | $606,103 | +6.3% | 5,579 | +5.6% | 0.00% | – |
Q2 2023 | $569,978 | -55.4% | 5,281 | -48.6% | 0.00% | -100.0% |
Q1 2023 | $1,279,083 | -40.3% | 10,268 | -28.0% | 0.00% | -50.0% |
Q4 2022 | $2,143,489 | -22.0% | 14,269 | -29.9% | 0.00% | -33.3% |
Q3 2022 | $2,747,000 | -20.0% | 20,364 | -11.5% | 0.00% | 0.0% |
Q2 2022 | $3,433,000 | -22.2% | 23,022 | -11.0% | 0.00% | -25.0% |
Q1 2022 | $4,412,000 | -58.1% | 25,865 | -36.7% | 0.00% | -55.6% |
Q4 2021 | $10,540,000 | +10.0% | 40,884 | +16.5% | 0.01% | 0.0% |
Q3 2021 | $9,579,000 | +68.6% | 35,088 | +38.2% | 0.01% | +80.0% |
Q2 2021 | $5,683,000 | +169.3% | 25,384 | +31.4% | 0.01% | +150.0% |
Q1 2021 | $2,110,000 | +775.5% | 19,323 | +553.7% | 0.00% | – |
Q4 2020 | $241,000 | – | 2,956 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
Systrade AG | 10,000 | $803,600 | 1.38% |
HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |